Elan Pharma (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.94 M
as on 23-10-2024
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.93 Cr
as on 23-10-2024
- Revenue 18.68%
(FY 2023)
- Profit 18.65%
(FY 2023)
- Ebitda 19.44%
(FY 2023)
- Net Worth 20.44%
(FY 2023)
- Total Assets 17.63%
(FY 2023)
About Elan Pharma (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.94 M.
The company has closed loans amounting to ₹4.93 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vidyadhar Sawant and Dandu Raju serve as directors at the Company.
- CIN/LLPIN
U24230MH1997PTC108497
- Company No.
108497
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Elan Pharma (India) Private Limited offer?
Elan Pharma (India) Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Medicine, Ayurvedic & Herbal Health Supplement, Herbal Supplements, Antihistamines, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Pain Killers.
Who are the key members and board of directors at Elan Pharma (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dandu Raju  | Managing Director | 04-Jun-1997 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vidyadhar Sawant | Whole-Time Director | 07-Sep-2013 | Current |
Financial Performance of Elan Pharma (India).
Elan Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.68% increase. The company also saw a substantial improvement in profitability, with a 18.65% increase in profit. The company's net worth Soared by an impressive increase of 20.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elan Pharma (India)?
In 2023, Elan Pharma (India) had a promoter holding of 96.12% and a public holding of 3.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elan Techno Services Private LimitedActive 24 years 5 monthsVidyadhar Sawant and Dandu Raju are mutual person
- Elan Bio-Ethicals Private LimitedActive 35 years 10 months
Vidyadhar Sawant and Dandu Raju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 28 Mar 2006 | ₹1.79 Cr | Satisfied |
Canara Bank Creation Date: 04 Feb 2003 | ₹0.38 M | Satisfied |
Canara Bank Creation Date: 05 Sep 2001 | ₹2.80 Cr | Satisfied |
How Many Employees Work at Elan Pharma (India)?
Elan Pharma (India) has a workforce of 321 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elan Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elan Pharma (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
